State KY
Clinical Trials in Kentucky
Recruiting clinical trials with at least one study location in Kentucky. Data updated daily from ClinicalTrials.gov.
Top Conditions in Kentucky
NCT07449702 Phase 2
Recruiting
An Open-Label Extension Study of ORKA-001 in Participants With Plaque Psoriasis
Condition
Plaque Psoriasis
Enrollment
80 pts
Location
United States, Canada
Sponsor
Oruka Therapeutics, Inc.
NCT06317662 Phase 2
Recruiting
Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer I...
Condition
Acute Leukemia of Ambiguous Lineage
Enrollment
153 pts
Location
United States, Puerto Rico
Sponsor
National Cancer Institute (NCI
NCT07106762 Phase 2, Phase 3
Recruiting
Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Me...
Condition
Urothelial Cancer
Enrollment
470 pts
Location
United States, Argentina, Australia
Sponsor
Bristol-Myers Squibb
NCT06856057 N/A
Recruiting
Improving Behavioral Health for Caregivers and Children After Pediatric Injury
Condition
Quality of Life
Enrollment
348 pts
Location
United States
Sponsor
Medical University of South Ca
NCT05112601 Phase 2
Recruiting
Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System...
Condition
Endometrial Adenocarcinoma
Enrollment
81 pts
Location
United States
Sponsor
National Cancer Institute (NCI
NCT05968937 Phase 2
Recruiting
Vaginal Baclofen Suppositories in Chronic Pelvic Pain
Condition
Chronic Pelvic Pain Syndrome
Enrollment
44 pts
Location
United States
Sponsor
University of Louisville
NCT05853367 Phase 1
Recruiting
Study of MK-0472 in Participants With Advanced/Metastatic Solid Tumors (MK-0472-...
Condition
Metastatic Solid Tumors
Enrollment
178 pts
Location
United States, Canada, Chile
Sponsor
Merck Sharp & Dohme LLC
NCT05174169 Phase 2, Phase 3
Recruiting
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Condition
Stage III Colon Cancer
Enrollment
1,912 pts
Location
United States, Canada, Puerto Rico
Sponsor
NRG Oncology
NCT06721962 Phase 1, Phase 2
Recruiting
Treatment of Moderate to Severe Refractory Crohn's Disease
Condition
Crohns Disease
Enrollment
39 pts
Location
United States
Sponsor
Tr1X, Inc.
NCT06520072 N/A
Recruiting
Mobile Apps for Preschool Parents (MAPP) Study
Condition
Obesity, Childhood
Enrollment
1,200 pts
Location
United States
Sponsor
Pamela Hull
NCT05642572 Phase 2
Recruiting
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer...
Condition
Recurrent Lung Non-Small Cell Carcinoma
Enrollment
66 pts
Location
United States
Sponsor
SWOG Cancer Research Network
NCT04929236 Phase 3
Recruiting
Study to Evaluate Safety and Efficacy of Different PANZYGA Dose Regimens in Pedi...
Condition
Pediatric Chronic Inflammatory Demyelinating Polyneuropathy
Enrollment
30 pts
Location
United States
Sponsor
Octapharma
NCT07061964 Phase 2
Recruiting
Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Rem...
Condition
Muscle Invasive Bladder Urothelial Carcinoma
Enrollment
111 pts
Location
United States
Sponsor
National Cancer Institute (NCI
NCT06378632 N/A
Recruiting
AN INTERNATIONAL, OBSERVATIONAL, BLINDED STUDY TO ASSESS THE PERFORMANCE OF THE ...
Condition
Heart Failure
Enrollment
500 pts
Location
United States, Israel, Spain
Sponsor
Cordio Medical
NCT05178056 N/A
Recruiting
Spinal Cord Stimulation and Respiration After Injury
Condition
Spinal Cord Injuries
Enrollment
30 pts
Location
United States
Sponsor
University of Louisville
NCT05633667 Phase 2
Recruiting
Study of Novel Treatment Combinations in Patients With Lung Cancer
Condition
Lung Cancer
Enrollment
270 pts
Location
United States, Brazil, Hong Kong
Sponsor
Gilead Sciences
NCT05164172 Phase 3
Recruiting
A Study With Eptinezumab in Children and Adolescents (6 to 17 Years) With Chroni...
Condition
Migraine
Enrollment
600 pts
Location
United States, Argentina, Canada
Sponsor
H. Lundbeck A/S
NCT04166409 Phase 3
Recruiting
A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients Wit...
Condition
Low Grade Astrocytoma
Enrollment
170 pts
Location
United States, Canada, Puerto Rico
Sponsor
National Cancer Institute (NCI
NCT06486428 N/A
Recruiting
Small Cell Lung Cancer Community Engagement to Eliminate Research Discepancies
Condition
Small-cell Lung Cancer
Enrollment
30 pts
Location
United States
Sponsor
Addario Lung Cancer Medical In
NCT07276399 Phase 3
Recruiting
A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared Wit...
Condition
Squamous Cell Carcinoma of Head and Neck
Enrollment
500 pts
Location
United States, Australia, Austria
Sponsor
Janssen Research & Development
NCT07258511 Phase 3
Recruiting
A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 ...
Condition
Multiple Myeloma
Enrollment
400 pts
Location
United States, Australia, Brazil
Sponsor
Janssen Research & Development
NCT06008093 Phase 3
Recruiting
A Study to Investigate the Efficacy of Durvalumab Plus Tremelimumab in Combinati...
Condition
Carcinoma, Non-Small-Cell Lung
Enrollment
280 pts
Location
United States
Sponsor
AstraZeneca
NCT06203600 Phase 2, Phase 3
Recruiting
Adding Nivolumab to Usual Treatment for People With Advanced Stomach or Esophage...
Condition
Advanced Esophageal Adenocarcinoma
Enrollment
224 pts
Location
United States
Sponsor
National Cancer Institute (NCI
NCT07353931 Phase 3
Recruiting
Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthri...
Condition
Osteoarthritis
Enrollment
900 pts
Location
United States, Argentina, Belgium
Sponsor
Eli Lilly and Company
NCT06784466 N/A
Recruiting
Coherent Sine Burst Electroporation (CSE) Ablation System US IDE Study for Patie...
Condition
Atrial Fibrillation (AF)
Enrollment
360 pts
Location
United States, Belgium, Croatia
Sponsor
Arga Medtech SA